NASDAQ:GRFS

Grifols Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Drug Manufacturers—General

Open Broker Account

$6.58

-0.200 (-2.95%)

At Close: Apr 17, 2024

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Grifols

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunogl... GRFS Profile

Golden Star

Ticker	Date	Change	Price
ITCI	Apr 05	12.05%	$68.44
AKR	Apr 05	0.665%	$16.53
SARK	Mar 28	16.07%	$26.88
ARCC	Mar 25	1.04%	$20.12
STT	Mar 19	0.262%	$72.62
GGB	Mar 19	0.468%	$4.27
CAG	Mar 18	7.16%	$28.22
JBI	Mar 15	1.29%	$14.72
MASI	Mar 14	3.34%	$132.20
CMC	Mar 14	5.04%	$53.19

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

Grifols Stock Insider Trading

About Grifols

Golden Star

Top Fintech Company